• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About
  • Consumer Info
  • Guideline Notes
  • Medicine and Media
  • Pharmacogenomics
  • Visit My Etsy Store

Digital PharmD

Informatics in Pharmacy

Depression

August 13, 2018 By Dr. G, PharmD

Print Friendly, PDF & Email

Diagnosis:

MDD – Major Depressive Disorder/Unipolar Disorder
At least five symptoms every day for at least 2 weeks.
Depressed mood = SIG E CAPS

  • Sleep disturbances
  • Interest in activities lost
  • Guilt or worthlessness feelings
  • Energy decreased
  • Concentration decreased
  • Appetite and weight changes
  • Psychomotor retardation
  • Suicidal ideation

Rating Scales:

  • HAM-D: Hamilton rating scale for depression – 18 moderate, 7 normal
  • CGT: Clinical Global Impression Scale
  • MADRS: Montgomery-Asberg Depression Rating Scale
  • PHQ-9: Patient Health Questionnaire
  • Beck Depression Inventory
  • Quick Inventory of Depressive Symptoms (self-rated)

Treatment:

  • Psychotherapy may have longer-lasting effects than drugs, but it takes longer to take effect.
  • All anti-depressants are equally as effective, but take 1-2 weeks for effect and 6-8 weeks for full effect.  Treat for at least 6 months.  An adequate trial is considered to be 4-8 weeks.  Look for at least a 50% decrease in symptoms.
  • SSRIs are the cheapest and most tolerated drug class: citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, vilazodone.  SNRIs are very similar, but also decrease seizure threshold: venlafaxine, desvenlafaxine, duloxetine, nefazodone, levomilnacipran
    • AE: diarrhea (especially sertraline), drowsiness (fluvoxamine and paroxetine are most sedating, fluoxetine and sertraline are most activating), anxiety, sexual disorder, serotonin syndrome (especially when combined with meperidine, tramadol, MAOI or linezolid), SIADH (especially in elderly), pulmonary HTN (especially paroxetine), weight gain (citalopram, escitalopram and fluoxetine are the most weight neutral)
    • Least likely for drug interactions: citalopram and escitalopram, fluoxetine and paroxetine.
    • Fluoxetine has the slowest onset and the longest half-life.
    • Duloxetine has an indication for diabetic neuropathy
    • Limit dose of citalopram to 40 mg due to QT prolongation
    • Fluoxetine 90 mg can be taken once weekly
    • Venlafaxine is known to cause withdrawal problems
    • Symptoms of serotonin withdrawal: dizziness, lightheadedness, feeling faint, shock-like sensations, anxiety, diarrhea, fatigue, gait instability, headache, insomnia, irritability, nausea and vomiting, tremor, visual disturbances and flu-like symptoms
    • Serotonin syndrome: MAOI, tramadol, dextromethorphan, meperidine, sympathomimetics, triptans, lithium, TCAs and SNRIs.  Symptoms include myoclonus, rigidity, tremors, incoordination, altered mental status, hypothermia, diaphoresis.  Use benzos and pressors for symptoms, cyproheptadine can be used to block serotonin
    • Patients may respond to a different SSRI or a SNRI if they don’t respond to one or they may want to change to another class.
    • May use a second agent to offset actions of another (using trazodone to treat SSRI induced insomnia)
    • Can add bupropion to SSRI if patient not responding
  • Tricyclic Antidepressants (TCAs): Limited use because of side effects.  Amitriptyline, imipramine, clomipramine, desipramine, nortriptyline.  They can cause orthostasis, conduction problems (increased QT), anticholinergic side effects, and withdrawn syndromes if abruptly discontinued.
  • Monoamine oxidase inhibitors (MAOIs): Non-selective – phenelzine and tranylcypromine.  Avoid tyramine-containing foods (aged cheese and meats) due to HTN crisis.
  • Mixed serotonergic meds: vilazodone, vortioxetine, trazodone, nefazodone, mirtazapine
  • Bupropion – decreases seizure threshold, may cause psychosis in susceptible individuals. May improve sexual dysfunction
  • Second generation anti-psychotics can be used to augment theraphy.  Most common: aripiprazole, brexipiprazole, quetipine.
  • Can try ketamine infusions, lithium, liothyronine, modanifil or scopolamine

Filed Under: Guideline Materials and Tips, Psychiatry

Primary Sidebar

Newsletter

More to See

What You Need to Know About the 2022 Avian Influenza Outbreak

March 20, 2022 By Dr. G, PharmD

Endocarditis Guideline Review

February 24, 2022 By Dr. G, PharmD

Sinus Troubles: When Should I See My Doctor

January 5, 2022 By Dr. G, PharmD

Tags

acid base acidosis acute coronary syndrome alkalosis analgesics anaphylaxis aortic dissection arrhythmia Beta-Blockers biostatistics blood pressure cardiac markers CHA2DS2-VasC cocaine COVID-19 diabetes diabetes inspidius Guidelines heart failure Heparin hypersensitivity hypertension hypovolemic shock intubation ionotropes journal club lipids LMWH medication safety morphine conversions myocardial infarction needs work NOAC NSTEMI obstructive shock pharmacoeconomics pheochromocytoma pressors reference materials right mi sedation septic shock shock STEMI Updated 2020

Footer

Medical Disclaimer

The medical information on this website is provided “as is” without any representations or warranties, express or implied. GoPharmD makes no representations or warranties in relation to the medical information on this website.

GoPharmD does not warrant that:

  • the medical information on this website will be constantly available, or available at all; or
  • the medical information on this website is complete, true, accurate, up-to-date, or non-misleading.
  • You must not rely on the information on this website as an alternative to medical advice from your doctor or other professional healthcare provider.
  • If you have any specific questions about any medical matter you should consult your doctor or other professional healthcare provider.

Recent

  • Smoking
  • What You Need to Know About the 2022 Avian Influenza Outbreak
  • Endocarditis Guideline Review
  • Sinus Troubles: When Should I See My Doctor
  • Common Pharmacogenomic SNPs and Interactions

Search

Tags

acid base acidosis acute coronary syndrome alkalosis analgesics anaphylaxis aortic dissection arrhythmia Beta-Blockers biostatistics blood pressure cardiac markers CHA2DS2-VasC cocaine COVID-19 diabetes diabetes inspidius Guidelines heart failure Heparin hypersensitivity hypertension hypovolemic shock intubation ionotropes journal club lipids LMWH medication safety morphine conversions myocardial infarction needs work NOAC NSTEMI obstructive shock pharmacoeconomics pheochromocytoma pressors reference materials right mi sedation septic shock shock STEMI Updated 2020